First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients

Aim. To evaluate the predictive value of RRM1, ERCCl, and BRCA1 expression in Chinese NSCLC patients treated with gemcitabine and cisplatin. Methods. Real-time fluorescent quantitative PCR was used to determine the RRM1, ERCC1, and BRCA1 mRNA expression levels of peripheral blood in late-stage NSCLC...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Li, Ying, Wang, Lin Run, Chen, Jian, Lou, Yan, Zhang, Guo Bing
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi Publishing Corporation 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3925578/
https://ncbi.nlm.nih.gov/pubmed/24591771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/960458
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia